This is the fifth survey assessing the capacity and needs of laboratories in the EU/EEA, with a focus on antigenic characterisation capability and capacity for SARS-CoV-2 viruses.
ECDC encourages the use of this protocol as a basis for studies aiming at assessing vaccine effectiveness in semi-closed settings following the identification of a COVID-19 outbreak, as its use in the EU/EEA can facilitate results comparability from different outbreak investigations.
This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to children aged 5 11 years.
These ECDC guidelines detail available options for NPI in various epidemiologic scenarios, assess the evidence for their effectiveness and address implementation issues, including potential barriers and facilitators.
This is the final report for the mapping study ‘Assessment of electronic health records (EHRs) for infectious disease surveillance, prevention and control’. The study was commissioned by ECDC and was delivered by RAND Europe. The objective of the project is to investigate the current status of EHR systems in the European Union and European Economic Area (EU/EEA) and the potential capacity for the use of these data for surveillance of infectious diseases within ECDC’s remit.
The objective of this scoping review is to obtain an estimate of the size and nature of the scientific literature available on digital technologies with the potential to benefit or disrupt key public health functions, focusing on infectious disease surveillance, prevention and control.
In 2019, the European Centre for Disease Prevention and Control (ECDC) initiated a project to assess the possible impact of technical advances on its key functions. The results of the project will serve as a source of information for ECDC and its main stakeholders in deciding how to prepare for, and possibly benefit from, technological advances to further improve communicable disease surveillance, prevention and control.
This document aims to help public health authorities in EU/EEA countries and the UK in their tracing and
management of persons, including healthcare workers, who have had contact with COVID-19 cases.
This document is the first update of the technical report ‘Options for the use of rapid antigen detection tests (RADTs) for COVID-19 in the EU/EEA’. It is intended to facilitate further discussions between Member States on the settings and purpose for which it is appropriate to use RADTs and summarises key considerations for their implementation. Reaching an agreement on settings and performance criteria will be critical for the success of EU/EEA-wide surveillance purposes and for measures related to cross-border travel.
This report seeks to review the progress made in the ECDC response plan to control and manage the threat of drug-resistant gonorrhoea in Europe over the preceding two years, using the data collected for 2019.